Abstract
Anticholinergic drugs impair one's ability to learn new material, even at routine clinically used doses. During the trihexyphenidyl phase of this double-blind crossover trial, elderly normal subjects complained of confusion and memory impairment and demonstrated a pattern of deficits in memory function compatible with that previously reported to result from anticholinergic drugs. The subjects neither complained of nor demonstrated memory impairment while taking amantadine, which is believed to exert its pharmacological effects upon extrapyramidal disorders via dopaminergic mechanism and does not appear to be associated with memory impairment. Anticholinergic drugs should be avoided whenever possible in the elderly and especially in those suffering dementia.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 573-577 |
| Number of pages | 5 |
| Journal | American Journal of Psychiatry |
| Volume | 144 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1987 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS